J&J Refines Direction For Ottava

Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and hopes to commence trials later this year.

To design, manufacture, launch and maintain a soft-tissue surgical robot, companies need hundreds of staff and tight control not only over the technical process, but also culture.

Keeping the team pinned to a core vision can be difficult. Reportedly, failures in this area have caused medtech giants...